www.fdanews.com/articles/62181-nobilon-biodiem-and-leading-u-s-scientists-developing-pandemic-avian-flu-vaccine
NOBILON, BIODIEM AND LEADING U.S. SCIENTISTS DEVELOPING PANDEMIC AVIAN FLU VACCINE
August 31, 2006
Scientists at Akzo Nobel's Nobilon International human vaccines business working to fight the threat of a global bird flu pandemic have received a major boost following the signing of a cooperative research and development agreement with the Centers for Disease Control and Prevention (CDC) in the United States.
MediLexicon